Limited Expansion of the New Self-Expandable Transcathether Aortic Valve Prosthesis (CoreValve Evolut R).
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 27106459.
- Also identified by DOI 10.1016/j.athoracsur.2015.08.089.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transcatheter aortic valve implantation (TAVI) has been established as a therapeutic option in patients with a high procedural risk presenting with severe aortic stenosis. Recent improvements of TAVI technology made it possible to treat degenerated bioprosthesis using the valve-in-valve implantation concept. The self-expanding CoreValve (Medtronic, Minneapolis, MN) prosthesis has recently been redesigned and was introduced into clinical practice. We report a case of a not fully expanded Medtronic CoreValve Evolut R after deploying a 26 mm prosthesis into a degenerated 25 mm Carpentier-Edwards Perimount prosthesis.
Medical subject headings
- Aortic Valve Stenosis
- Bioprosthesis
- Heart Valve Prosthesis
- Transcatheter Aortic Valve Replacement